Gynecologic oncology
Audio Summaries

Exploring delays in primary gynecologic and breast cancer diagnosis after emergency department presentation

Mar 20, 2026

The authors aimed to identify factors that influence the diagnosis timing of endometrial, ovarian, cervical, and breast cancers following emergency department (ED) visits. Their findings reveal that gynecologic cancers are diagnosed more frequently during ED encounters and have shorter diagnosis intervals compared to breast cancer, with factors such as comorbidities and access to primary care significantly affecting diagnosis likelihood and post-ED intervals.

Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis

Mar 17, 2026

The authors aimed to compare long-term survival outcomes between robotic-assisted and traditional laparoscopic surgery for stage I endometrial cancer using data from the National Cancer Database. Their analysis of 127,342 patients revealed no significant differences in overall survival rates between the two surgical approaches, with 5-year survival rates of 91.7% for robotic surgery and 91.4% for traditional laparoscopic surgery. The findings suggest that both surgical methods yield excellent survival outcomes, but further research is needed to assess potential late recurrences and deaths.

Enhancing engagement in biobanking research among Black women with endometrial cancer

Mar 15, 2026

The authors aimed to enhance biobanking research participation among Black women with endometrial cancer by identifying priority elements of return of value (ROV) practices. Through a mixed-methods study involving surveys and focus groups with Black EC survivors, they found that participants valued the return of genetic and lifestyle information over monetary compensation, highlighting the importance of trust and community health in research engagement. The study resulted in 14 community-validated recommendations to improve participation in translational research for underrepresented populations.

Noncompete agreements in job contracts: Knowledge and opinion of practicing gynecologic oncologist members of Society of Gynecologic Oncology

Mar 14, 2026

The authors aimed to assess the prevalence, awareness, and attitudes of practicing gynecologic oncologists towards noncompete agreements in their employment contracts. Their survey revealed that a significant majority of respondents were subject to such clauses, with many indicating that these agreements influenced their job-seeking decisions and expressing a negative view of them. The findings suggest a need for further evaluation of the implications of noncompete clauses on physician mobility and geographic disparities in the field of gynecologic oncology.

The role of hyperthermic intraperitoneal chemotherapy in newly diagnosed and recurrent ovarian cancer: A time-to-event meta-analysis of randomized trials

Mar 14, 2026

The authors aimed to evaluate the effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) in improving survival outcomes for patients with newly diagnosed and recurrent ovarian cancer. Their meta-analysis of seven randomized trials found that HIPEC significantly enhanced progression-free survival and overall survival in newly diagnosed cases treated with interval cytoreductive surgery, while showing no significant benefits in recurrent cases. The study suggests that HIPEC, particularly with a 90-minute protocol, is beneficial for newly diagnosed ovarian cancer without a substantial increase in severe adverse effects, but its role in recurrent disease remains unclear.

Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis

Mar 13, 2026

The authors aimed to investigate whether vitamin D enhances the progestin-mediated inhibition of fallopian tube (FT) carcinogenesis in a mouse model and to explore the underlying cellular mechanisms. Their findings indicate that the combination of progestin and vitamin D synergistically reduces p53-altered cell proliferation and enhances apoptosis, suggesting that this combination could serve as a more effective chemopreventive strategy for fallopian tube and ovarian cancer compared to either agent alone.

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions

Mar 12, 2026

This study investigates the risk of peritoneal cancer (PC) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA1/2 pathogenic variants and the impact of serous tubal intraepithelial carcinoma (STIC) lesions on this risk. The authors found that while the overall incidence of PC was low, women with STIC detected during RRSO had a significantly higher 5-year risk of developing PC. The results underscore the need for early RRSO and tailored follow-up strategies for genetically at-risk women.

Lymphatic mapping and sentinel node biopsy in invasive Vulvar Paget's disease: A retrospective study and systematic review of the literature

Mar 11, 2026

This study aimed to evaluate the oncologic outcomes of sentinel node biopsy (SNB) in patients with invasive Vulvar Paget's Disease (iVPD). The findings indicate that SNB is a feasible and effective method for nodal staging in iVPD, with a notable rate of metastatic sentinel nodes in patients with microinvasive disease, suggesting the need for inguino-femoral surgical staging in this population. Overall, the study supports the expansion of SNB indications for vulvar neoplasms.

Assessment of survival and clinicopathologic characteristics associated with lymph node isolated tumor cells in epithelial ovarian cancer

Mar 10, 2026

The authors aimed to evaluate the incidence, characteristics, and survival outcomes associated with isolated tumor cells (ITCs) in regional lymph nodes of patients with epithelial ovarian cancer. Their retrospective analysis of 15,484 patients revealed that while ITCs were more common in higher T classifications and low-grade serous carcinoma, they were not statistically linked to overall survival. The findings suggest that the presence of ITCs may not serve as a prognostic factor for short-term survival in this patient population.

Demographics, clinicopathological features, and survival outcomes of women with endometrial neuroendocrine tumors

Mar 5, 2026

The authors aimed to analyze the demographics, clinicopathological features, and survival outcomes of women with endometrial neuroendocrine tumors (ENETs) to evaluate how these factors influence treatment outcomes. Their study found that ENETs are often diagnosed at advanced stages and that combined adjuvant chemotherapy and radiotherapy significantly improve progression-free and overall survival. Additionally, the research highlighted common genetic mutations and the prevalence of mismatch repair deficiency in these tumors, suggesting potential therapeutic targets for future treatment strategies.